Overview

Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients

Status:
Completed
Trial end date:
2017-08-17
Target enrollment:
Participant gender:
Summary
The study aims to describe the characteristics and the methods of management and follow-up of patients treated with fidaxomicin for Clostridium difficile infection (CDI).
Details
Lead Sponsor:
Astellas Pharma S.A.S.
Treatments:
Fidaxomicin